Matches in SemOpenAlex for { <https://semopenalex.org/work/W2051226264> ?p ?o ?g. }
Showing items 1 to 77 of
77
with 100 items per page.
- W2051226264 endingPage "62" @default.
- W2051226264 startingPage "55" @default.
- W2051226264 abstract "The prevalence of diabetes and its complications is increasing worldwide. Among the microvascular complications, diabetic nephropathy is the most frequent cause of end-stage renal disease. Although angiotensin-converting-enzyme inhibitors have been cited as the first line of therapy for the management of microalbuminuria, the rate of remission from microalbuminuria to normoalbuminuria has been lower than the expected. Furthermore, due to the elevated frequency of side effects of the rennin-angiotensin blockers new approaches for the treatment of microalbuminuria are needed. Pentoxifylline, a xanthine derivate drug with hemorheologic properties and primarily indicated for the therapy of disturbances of blood fluidity, is also an antagonist of adenosine 2 receptors and have antiinflammatory and immunomodulatory effects, properties that promote beneficial changes in the blood flow conditions and kidney function. Current evidence shows that the short-term use of pentoxifylline has low side-effects, reduces both proteinuria and microalbuminuria in subjects with diabetes, and is as effective as captopril in the reduction of microalbuminuria in non-hypertensive type 2 diabetic patients. Although this data suggests that pentoxifylline could be useful for preventing the development of end-stage renal disease is necessary to conduct long-term studies to evaluate the role of pentoxifylline in the treatment of diabetic nephropathy and the prevention of chronic renal failure. In this article, we review the clinical evidence that show the efficacy of pentoxifylline in the management of microalbuminuria in diabetic patients. Keywords: Pentoxifylline, Diabetic nephropathy, Microalbuminuria, Proteinuria" @default.
- W2051226264 created "2016-06-24" @default.
- W2051226264 creator A5039250608 @default.
- W2051226264 creator A5048743477 @default.
- W2051226264 date "2008-02-01" @default.
- W2051226264 modified "2023-10-18" @default.
- W2051226264 title "Efficacy of Pentoxifylline in the Management of Microalbuminuria in Patients with Diabetes" @default.
- W2051226264 doi "https://doi.org/10.2174/157339908783502343" @default.
- W2051226264 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18220696" @default.
- W2051226264 hasPublicationYear "2008" @default.
- W2051226264 type Work @default.
- W2051226264 sameAs 2051226264 @default.
- W2051226264 citedByCount "17" @default.
- W2051226264 countsByYear W20512262642012 @default.
- W2051226264 countsByYear W20512262642013 @default.
- W2051226264 countsByYear W20512262642014 @default.
- W2051226264 countsByYear W20512262642015 @default.
- W2051226264 countsByYear W20512262642016 @default.
- W2051226264 countsByYear W20512262642017 @default.
- W2051226264 countsByYear W20512262642018 @default.
- W2051226264 countsByYear W20512262642020 @default.
- W2051226264 countsByYear W20512262642021 @default.
- W2051226264 crossrefType "journal-article" @default.
- W2051226264 hasAuthorship W2051226264A5039250608 @default.
- W2051226264 hasAuthorship W2051226264A5048743477 @default.
- W2051226264 hasConcept C126322002 @default.
- W2051226264 hasConcept C126894567 @default.
- W2051226264 hasConcept C134018914 @default.
- W2051226264 hasConcept C159641895 @default.
- W2051226264 hasConcept C27016395 @default.
- W2051226264 hasConcept C2779561371 @default.
- W2051226264 hasConcept C2779611605 @default.
- W2051226264 hasConcept C2779922275 @default.
- W2051226264 hasConcept C2780091579 @default.
- W2051226264 hasConcept C2780404050 @default.
- W2051226264 hasConcept C2781184683 @default.
- W2051226264 hasConcept C2781203188 @default.
- W2051226264 hasConcept C555293320 @default.
- W2051226264 hasConcept C71924100 @default.
- W2051226264 hasConcept C84393581 @default.
- W2051226264 hasConceptScore W2051226264C126322002 @default.
- W2051226264 hasConceptScore W2051226264C126894567 @default.
- W2051226264 hasConceptScore W2051226264C134018914 @default.
- W2051226264 hasConceptScore W2051226264C159641895 @default.
- W2051226264 hasConceptScore W2051226264C27016395 @default.
- W2051226264 hasConceptScore W2051226264C2779561371 @default.
- W2051226264 hasConceptScore W2051226264C2779611605 @default.
- W2051226264 hasConceptScore W2051226264C2779922275 @default.
- W2051226264 hasConceptScore W2051226264C2780091579 @default.
- W2051226264 hasConceptScore W2051226264C2780404050 @default.
- W2051226264 hasConceptScore W2051226264C2781184683 @default.
- W2051226264 hasConceptScore W2051226264C2781203188 @default.
- W2051226264 hasConceptScore W2051226264C555293320 @default.
- W2051226264 hasConceptScore W2051226264C71924100 @default.
- W2051226264 hasConceptScore W2051226264C84393581 @default.
- W2051226264 hasIssue "1" @default.
- W2051226264 hasLocation W20512262641 @default.
- W2051226264 hasLocation W20512262642 @default.
- W2051226264 hasOpenAccess W2051226264 @default.
- W2051226264 hasPrimaryLocation W20512262641 @default.
- W2051226264 hasRelatedWork W2054881161 @default.
- W2051226264 hasRelatedWork W2057061592 @default.
- W2051226264 hasRelatedWork W2083212837 @default.
- W2051226264 hasRelatedWork W2129113925 @default.
- W2051226264 hasRelatedWork W2376102491 @default.
- W2051226264 hasRelatedWork W2411434392 @default.
- W2051226264 hasRelatedWork W2474822885 @default.
- W2051226264 hasRelatedWork W2991868140 @default.
- W2051226264 hasRelatedWork W4296511598 @default.
- W2051226264 hasRelatedWork W2185412569 @default.
- W2051226264 hasVolume "4" @default.
- W2051226264 isParatext "false" @default.
- W2051226264 isRetracted "false" @default.
- W2051226264 magId "2051226264" @default.
- W2051226264 workType "article" @default.